Intellia Therapeutics Inc (NTLA)
Retained Earnings
-$2.79B
Quarterly · Period ending: · USD
NTLA Retained Earnings
Latest reported-$2.79Bperiod ending
Latest reported-$2.79Bperiod ending
NTLA Quarterly Retained Earnings (-$9.54M → -$2.79B)
Quarterly retained earnings
High-resolution chart · PNG
NTLA retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -2,792,959,000 | |
| -2,686,325,000 | |
| -2,590,094,000 | |
| -2,494,308,000 | |
| -2,392,984,000 | |
| -2,291,729,000 | |
| -2,177,400,000 | |
| -2,048,502,000 | |
| -1,912,790,000 | |
| -1,765,815,000 | |
| -1,658,379,000 | |
| -1,526,218,000 | |
| -1,403,994,000 | |
| -1,280,313,000 | |
| -1,177,187,000 | |
| -1,063,780,000 | |
| -950,551,000 | |
| -849,873,000 | |
| -703,001,000 | |
| -621,764,000 | |
| -550,120,000 | |
| -481,314,000 | |
| -435,109,000 | |
| -392,917,000 | |
| -365,077,000 | |
| -332,684,000 | |
| -300,878,000 | |
| -272,602,000 | |
| -248,968,000 | |
| -223,285,000 | |
| -201,025,000 | |
| -181,959,000 | |
| -159,257,000 | |
| -137,038,000 | |
| -121,113,000 | |
| -97,150,000 | |
| -81,794,000 | |
| -66,201,000 | |
| -53,570,000 | |
| -43,007,000 | |
| -35,525,000 | |
| -28,625,000 | |
| -21,936,000 | |
| -16,691,000 | |
| -13,672,000 | |
| 0 | |
| -9,539,000 |